Diseases & Disorders
(G03)
IRS Verified
DX Registered
990 on File
INTERNATIONAL GYNECOLOGIC CANCER SOCIETY INC
Financial strength (30%)
99/100
Reliability (20%)
50/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
Register and add impact metrics to be rated above three stars
CharityAI™ Score
Not yet evaluated
Mission Statement
The International Gynecologic Cancer Society (IGCS) has been uniting the globe in the fight against gynecologic cancer by contributing to the prevention, treatment and study of gynecologic cancer, as well as improvement in the quality of life among women suffering from gynecologic cancer throughout the world.
Financial Overview — FY 2024
$2.8M
Total Revenue
$2.1M
Total Expenses
$3.0M
Net Assets
4
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
77.6%
Fundraising Efficiency
N/A
Operating Reserve
17.14x
Liability-to-Asset
11.0%
Revenue Diversification
50.0%
Executive Compensation
$392K
Compared with Peers
FY 2024
Compared with 638 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
77.6% | 82.3% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
22.4% | 11.5% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.8% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
17.1 mo | 11.4 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
11.0% | 12.7% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
50.0% | 91.5% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
23.0% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
1.4% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
25.8% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $2.8M | $2.1M | $3.0M | 77.6% | 4 |
| 2023 | $2.3M | $2.0M | $2.2M | 76.9% | 4 |
| 2022 | $1.6M | $1.6M | $2.0M | 75.6% | 4 |
| 2021 | $1.7M | $1.5M | N/A | — | 3 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.